Waters Corporation (WAT) EV/FCF Ratio: 133.18x
Is Waters Corporation’s EV/FCF ratio high or low?
Waters Corporation's EV/FCF ratio of 133.18x is 221% above its 5-year average of 41.43x, near the high end of its 5-year range (28.64x–138.69x).
The EV/FCF ratio for Waters Corporation (WAT) is 133.18x as of Wednesday, June 10, 2026. It is above its 12-month average by 207.13% (43.36x).
WAT EV/FCF Ratio Chart
WAT Average EV/FCF Ratio Chart
WAT Current vs Average EV/FCF Ratio Chart
WAT EV/FCF Ratio Metrics
EV/FCF RATIO
133.18x
EV/FCF RATIO AVG TTM
43.36x
EV/FCF RATIO AVG 3Y
43.04x
EV/FCF RATIO AVG 5Y
41.43x
EV/FCF RATIO AVG 10Y
35.75x
EV/FCF RATIO AVG 15Y
32.11x
EV/FCF RATIO AVG 20Y
29.37x
CURRENT VS TTM AVG
+207.13%
CURRENT VS 3Y AVG
+209.45%
CURRENT VS 5Y AVG
+221.43%
CURRENT VS 10Y AVG
+272.49%
CURRENT VS 15Y AVG
+314.78%
CURRENT VS 20Y AVG
+353.49%
WAT Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | $23.83B | 133.18x | 43.36x | 43.04x | 41.43x |
| Mettler-Toledo International Inc. (MTD) | $22.85B | 31.65x | 33.77x | 33.51x | 38.38x |
| BioNTech SE (BNTX) | $21.81B | 7.13x | 22.05x | 6.21x | 11.27x |
| Veeva Systems Inc. (VEEV) | $26.73B | 48.97x | 29.32x | 32.91x | 38.27x |
| Biogen Inc. (BIIB) | $29.00B | 12.34x | 12.71x | 21.65x | 21.18x |
| DexCom, Inc. (DXCM) | $29.24B | 21.01x | 37.45x | 66.82x | 181.62x |
| Moderna, Inc. (MRNA) | $18.40B | N/A | 26.90x | 26.23x | 26.23x |
| IQVIA Holdings Inc. (IQV) | $30.60B | 11.70x | 19.22x | 27.05x | 27.70x |
| Hologic, Inc. (HOLX) | $16.97B | 17.53x | 16.89x | 18.61x | 15.13x |
| Medline Inc. (MDLN) | $30.90B | 26.55x | 27.74x | 27.74x | 27.74x |
Cash Flow Valuation Comparison
EV/FCF
133.2x
P/FCF
113.8x
FCF Yield
0.88%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
Waters Corporation EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Waters Corporation EV/FCF Ratio FAQ
- What is the EV/FCF ratio for Waters Corporation (WAT)?
- The EV/FCF ratio for WAT stock is 133.18x.
- Is Waters Corporation's EV/FCF ratio high or low?
- Waters Corporation's EV/FCF ratio of 133.18x is 221% above its 5-year average of 41.43x, near the high end of its 5-year range (28.64x–138.69x).
- What is the TTM average EV/FCF ratio for Waters Corporation (WAT)?
- The TTM average EV/FCF ratio for WAT stock is 43.36x.
- What is the 3Y average EV/FCF ratio for Waters Corporation (WAT)?
- The 3Y average EV/FCF ratio for WAT stock is 43.04x.
- What is the 5Y average EV/FCF ratio for Waters Corporation (WAT)?
- The 5Y average EV/FCF ratio for WAT stock is 41.43x.
- What is the 10Y average EV/FCF ratio for Waters Corporation (WAT)?
- The 10Y average EV/FCF ratio for WAT stock is 35.75x.
- What is the 15Y average EV/FCF ratio for Waters Corporation (WAT)?
- The 15Y average EV/FCF ratio for WAT stock is 32.11x.
- What is the 20Y average EV/FCF ratio for Waters Corporation (WAT)?
- The 20Y average EV/FCF ratio for WAT stock is 29.37x.
Waters Corporation EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-10 | 133.18x |
| 2026-06-09 | 134.83x |
| 2026-06-08 | 132.40x |
| 2026-06-05 | 133.02x |
| 2026-06-04 | 136.48x |
| 2026-06-03 | 137.51x |
| 2026-06-02 | 135.07x |
| 2026-06-01 | 137.01x |
| 2026-05-29 | 138.69x |
| 2026-05-28 | 133.43x |
| 2026-05-27 | 125.81x |
| 2026-05-26 | 124.71x |
| 2026-05-22 | 125.87x |
| 2026-05-21 | 125.44x |
| 2026-05-20 | 125.54x |
| 2026-05-19 | 123.04x |
| 2026-05-18 | 122.70x |
| 2026-05-15 | 121.78x |
| 2026-05-14 | 123.02x |
| 2026-05-13 | 123.56x |
| 2026-05-12 | 128.93x |
| 2026-05-11 | 40.21x |
| 2026-05-08 | 40.99x |
| 2026-05-07 | 40.48x |
| 2026-05-06 | 40.37x |
| 2026-05-05 | 39.60x |
| 2026-05-04 | 35.09x |
| 2026-05-01 | 35.67x |
| 2026-04-30 | 35.91x |
| 2026-04-29 | 34.02x |
| 2026-04-28 | 34.97x |
| 2026-04-27 | 34.86x |
| 2026-04-24 | 35.98x |
| 2026-04-23 | 36.13x |
| 2026-04-22 | 38.69x |
| 2026-04-21 | 38.79x |
| 2026-04-20 | 38.83x |
| 2026-04-17 | 37.96x |
| 2026-04-16 | 36.99x |
| 2026-04-15 | 37.79x |
| 2026-04-14 | 38.32x |
| 2026-04-13 | 37.62x |
| 2026-04-10 | 37.10x |
| 2026-04-09 | 36.84x |
| 2026-04-08 | 36.94x |
| 2026-04-07 | 35.70x |
| 2026-04-06 | 35.34x |
| 2026-04-02 | 35.36x |
| 2026-04-01 | 34.87x |
| 2026-03-31 | 34.64x |
| 2026-03-30 | 34.15x |
| 2026-03-27 | 33.69x |
| 2026-03-26 | 34.95x |
| 2026-03-25 | 35.14x |
| 2026-03-24 | 35.10x |
| 2026-03-23 | 35.09x |
| 2026-03-20 | 34.77x |
| 2026-03-19 | 34.84x |
| 2026-03-18 | 34.34x |
| 2026-03-17 | 34.55x |
| 2026-03-16 | 33.78x |
| 2026-03-13 | 33.40x |
| 2026-03-12 | 33.04x |
| 2026-03-11 | 34.61x |
| 2026-03-10 | 34.85x |
| 2026-03-09 | 35.51x |
| 2026-03-06 | 35.17x |
| 2026-03-05 | 36.61x |
| 2026-03-04 | 36.99x |
| 2026-03-03 | 36.23x |
| 2026-03-02 | 35.69x |
| 2026-02-27 | 37.03x |
| 2026-02-26 | 37.41x |
| 2026-02-25 | 37.04x |
| 2026-02-24 | 37.80x |
| 2026-02-23 | 37.96x |
| 2026-02-20 | 34.70x |
| 2026-02-19 | 34.24x |
| 2026-02-18 | 34.13x |
| 2026-02-17 | 33.53x |
| 2026-02-13 | 33.72x |
| 2026-02-12 | 33.37x |
| 2026-02-11 | 34.30x |
| 2026-02-10 | 34.08x |
| 2026-02-09 | 34.19x |
| 2026-02-06 | 39.45x |
| 2026-02-05 | 39.02x |
| 2026-02-04 | 39.75x |
| 2026-02-03 | 39.22x |
| 2026-02-02 | 39.26x |
| 2026-01-30 | 38.41x |
| 2026-01-29 | 38.85x |
| 2026-01-28 | 39.82x |
| 2026-01-27 | 40.32x |
| 2026-01-26 | 40.40x |
| 2026-01-23 | 40.54x |
| 2026-01-22 | 41.35x |
| 2026-01-21 | 40.98x |
| 2026-01-20 | 39.71x |
| 2026-01-16 | 40.05x |
| 2026-01-15 | 40.77x |
| 2026-01-14 | 40.63x |
| 2026-01-13 | 40.71x |
| 2026-01-12 | 40.68x |
| 2026-01-09 | 40.98x |
| 2026-01-08 | 40.97x |
| 2026-01-07 | 41.25x |
| 2026-01-06 | 41.36x |
| 2026-01-05 | 40.81x |
| 2026-01-02 | 39.52x |
| 2025-12-31 | 39.31x |
| 2025-12-30 | 39.72x |
| 2025-12-29 | 39.83x |
| 2025-12-26 | 39.92x |
| 2025-12-24 | 39.80x |
| 2025-12-23 | 39.64x |
| 2025-12-22 | 39.73x |
| 2025-12-19 | 39.13x |
| 2025-12-18 | 38.96x |
| 2025-12-17 | 39.04x |
| 2025-12-16 | 39.18x |
| 2025-12-15 | 39.86x |
| 2025-12-12 | 39.85x |
| 2025-12-11 | 40.53x |
| 2025-12-10 | 40.89x |
| 2025-12-09 | 39.93x |
| 2025-12-08 | 40.59x |
| 2025-12-05 | 40.79x |
| 2025-12-04 | 40.94x |
| 2025-12-03 | 41.07x |
| 2025-12-02 | 41.17x |
| 2025-12-01 | 41.09x |
| 2025-11-28 | 41.64x |
| 2025-11-26 | 42.01x |
| 2025-11-25 | 42.55x |
| 2025-11-24 | 41.26x |
| 2025-11-21 | 40.71x |
| 2025-11-20 | 39.19x |
| 2025-11-19 | 38.95x |
| 2025-11-18 | 38.99x |
| 2025-11-17 | 39.12x |
| 2025-11-14 | 39.26x |
| 2025-11-13 | 39.25x |
| 2025-11-12 | 40.05x |
| 2025-11-11 | 39.93x |
| 2025-11-10 | 38.98x |
| 2025-11-07 | 38.50x |
| 2025-11-06 | 38.45x |
| 2025-11-05 | 38.53x |
| 2025-11-04 | 38.07x |
| 2025-11-03 | 35.18x |
| 2025-10-31 | 35.56x |
| 2025-10-30 | 34.92x |
| 2025-10-29 | 34.97x |
| 2025-10-28 | 35.21x |
| 2025-10-27 | 35.77x |
| 2025-10-24 | 36.52x |
| 2025-10-23 | 36.15x |
| 2025-10-22 | 35.47x |
| 2025-10-21 | 35.53x |
| 2025-10-20 | 34.95x |
| 2025-10-17 | 34.12x |
| 2025-10-16 | 34.15x |
| 2025-10-15 | 33.91x |
| 2025-10-14 | 33.98x |
| 2025-10-13 | 34.29x |
| 2025-10-10 | 33.77x |
| 2025-10-09 | 33.72x |
| 2025-10-08 | 33.45x |
| 2025-10-07 | 32.55x |
| 2025-10-06 | 33.45x |
| 2025-10-03 | 33.52x |
| 2025-10-02 | 32.90x |
| 2025-10-01 | 32.69x |
| 2025-09-30 | 30.77x |
| 2025-09-29 | 29.77x |
| 2025-09-26 | 29.99x |
| 2025-09-25 | 29.61x |
| 2025-09-24 | 30.08x |
| 2025-09-23 | 30.71x |
| 2025-09-22 | 31.03x |
| 2025-09-19 | 30.87x |
| 2025-09-18 | 31.40x |
| 2025-09-17 | 31.14x |
| 2025-09-16 | 31.08x |
| 2025-09-15 | 30.69x |
| 2025-09-12 | 30.34x |
| 2025-09-11 | 31.02x |
| 2025-09-10 | 30.12x |
| 2025-09-09 | 30.84x |
| 2025-09-08 | 31.69x |
| 2025-09-05 | 31.40x |
| 2025-09-04 | 30.76x |
| 2025-09-03 | 29.83x |
| 2025-09-02 | 30.45x |
| 2025-08-29 | 30.96x |
| 2025-08-28 | 30.56x |
| 2025-08-27 | 30.27x |
| 2025-08-26 | 30.41x |
| 2025-08-25 | 30.69x |
| 2025-08-22 | 31.00x |
| 2025-08-21 | 29.87x |
| 2025-08-20 | 30.47x |
| 2025-08-19 | 30.57x |
| 2025-08-18 | 29.77x |
| 2025-08-15 | 29.97x |
| 2025-08-14 | 30.16x |
| 2025-08-13 | 30.48x |
| 2025-08-12 | 29.39x |
| 2025-08-11 | 28.79x |
| 2025-08-08 | 28.98x |
| 2025-08-07 | 28.67x |
| 2025-08-06 | 28.64x |
| 2025-08-05 | 28.98x |
| 2025-08-04 | 29.40x |
| 2025-08-01 | 29.86x |
| 2025-07-31 | 29.71x |
| 2025-07-30 | 30.70x |
| 2025-07-29 | 31.10x |
| 2025-07-28 | 31.02x |
| 2025-07-25 | 31.08x |
| 2025-07-24 | 30.64x |
| 2025-07-23 | 30.37x |
| 2025-07-22 | 29.58x |
| 2025-07-21 | 29.02x |
| 2025-07-18 | 29.59x |
| 2025-07-17 | 30.49x |
| 2025-07-16 | 29.78x |
| 2025-07-15 | 29.78x |
| 2025-07-14 | 31.19x |
| 2025-07-11 | 35.89x |
| 2025-07-10 | 35.93x |
| 2025-07-09 | 35.54x |
| 2025-07-08 | 35.40x |
| 2025-07-07 | 35.30x |
| 2025-07-03 | 35.63x |
| 2025-07-02 | 35.80x |
| 2025-07-01 | 36.29x |
| 2025-06-30 | 35.52x |
| 2025-06-27 | 35.84x |
| 2025-06-26 | 36.09x |
| 2025-06-25 | 35.61x |
| 2025-06-24 | 35.30x |
| 2025-06-23 | 34.92x |
| 2025-06-20 | 34.90x |
| 2025-06-18 | 34.59x |
| 2025-06-17 | 34.75x |
| 2025-06-16 | 35.40x |
| 2025-06-13 | 34.87x |
| 2025-06-12 | 35.57x |
| 2025-06-11 | 35.23x |
| 2025-06-10 | 35.60x |
| 2025-06-09 | 35.45x |
| 2025-06-06 | 35.72x |
| 2025-06-05 | 35.26x |
| 2025-06-04 | 35.92x |
| 2025-06-03 | 35.55x |
| 2025-06-02 | 35.00x |
| 2025-05-30 | 35.54x |
| 2025-05-29 | 36.12x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra